Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Mesothelioma, Malignant 2Melanoma 2Glioblastoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Solitary Fibrous Tumor, Pleural 1Primary Myelofibrosis 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Metastatic Non-hematologic Malignancies 1Meningioma 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 57fludarabine phosphate 48Tacrolimus 39Peripheral Blood Stem Cell Transplantation 37Busulfan 36Mycophenolic Acid 34Whole-Body Irradiation 31Antilymphocyte Serum 28Methotrexate 26Cyclosporine 25fludarabine 23Melphalan 18Filgrastim 15Radiotherapy 14thymoglobulin 12ruxolitinib 12Methylprednisolone 12Cord Blood Stem Cell Transplantation 12Stem Cell Transplantation 11Sirolimus 11Psychiatric Rehabilitation 9Flow Cytometry 9Etoposide 9Specimen Handling 7Granulocyte Colony-Stimulating Factor 7merphos 6Therapeutics 6Decitabine 6Cyclosporins 6Azacitidine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Primary Myelofibrosis × vatalanib × Clear all
NCT00088231 2012-01-20

PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP

M.D. Anderson Cancer Center

Phase 1/2 Completed
9 enrolled
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡